Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00112411 · ClinicalTrials.gov registry record · Phase 2
Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
A Phase 2 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00112411 is a Phase 2 study that has completed, run by Teva Branded Pharmaceutical Products R&D.
The verdict
NCT00112411, a Phase 2 study, has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study is designed to evaluate the single-dose effectiveness of two bronchodilator inhalers given at two dose levels in pediatric asthma patients.
Interventions
- DRUG Bronchodilator
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-06-30 |
| Est. Completion | 2005-09-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00112411
The ClinicalTrials.gov registry entry for NCT00112411 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Teva Branded Pharmaceutical Products R&D, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bronchodilator is the first listed.
NCT00112411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00112411 about?
NCT00112411 is a clinical study titled "Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics". This study is designed to evaluate the single-dose effectiveness of two bronchodilator inhalers given at two dose levels in pediatric asthma patients.
What is the current status of trial NCT00112411?
This trial is currently completed. It is a Phase 2 study. The study started on 2005-06-30. Estimated completion is 2005-09-30.
What interventions are being tested in trial NCT00112411?
The interventions under investigation include: Bronchodilator (DRUG).
Who is sponsoring clinical trial NCT00112411?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.